Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Context Therapeutics Inc have a median target of 7.50, with a high estimate of 10.00 and a low estimate of 4.50. The median estimate represents a 400.00% increase from the last price of 1.50.
High | 566.7% | 10.00 |
Med | 400.0% | 7.50 |
Low | 200.0% | 4.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 24, 2025.
Average growth rate | -83.92% |
Average growth rate | +6.75% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼